•
Mar 31, 2021

Tscan Therapeutics Q1 2021 Earnings Report

Total Revenue
$2.03M
EPS
-$0.331
Previous year: -$0.231
+42.9%
Gross Profit
-$5.31M
Previous year: -$4.3M
+23.6%

Tscan Therapeutics

Tscan Therapeutics

Tscan Therapeutics Revenue by Segment